Assenagon Asset Management S.A.

Position in ROIV — Roivant Sciences Ltd.

CIK 1546007 SENNINGERBERG, N4

Position in ROIV

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$295,964,871

+$99,946,154 QoQ

Shares Held

8,362,952

+18.2% QoQ

Ownership

1.16%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#14

of 489 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. ROIV ranks #2 (15.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd. This page	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc.	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$295,964,871	8,362,952	+18.2%	Shares	Sole	2026-07-08
2026-03-31	$196,018,717	7,076,488	+2.0%	Shares	Sole	2026-04-20
2025-12-31	$150,535,330	6,937,112	+11507.5%	Shares	Sole	2026-01-09
2025-09-30	$904,229	59,764	+4.8%	Shares	Sole	2025-10-07
2025-06-30	$642,761	57,033	+0.9%	Shares	Sole	2025-07-11
2025-03-31	$570,458	56,537	-94.5%	Shares	Sole	2025-04-15
2024-03-31	$10,739,195	1,018,899	-4.2%	Shares	Sole	2024-04-24
2023-12-31	$11,941,892	1,063,392	+195.7%	Shares	Sole	2024-01-17
2023-09-30	$4,199,684	359,562	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.